New Zealand Survey Finds Adult Daily Vaping Prevalence at 11.7%, Concentrated Among Youth and Disadvantaged Groups）

Dec.05.2025

A survey report released by the Public Health Communication Centre Aotearoa shows that despite New Zealand implementing stricter vaping regulations in 2025, including a ban on disposable products and tighter flavour restrictions, daily vaping rates continue to rise. The research body urges close monitoring of behavioural changes following the new rules coming into force.

Key Takeaways

The daily vaping rate among New Zealand adults aged 15 and over has reached 11.7%, with particularly high prevalence among those aged 18–24 (23.0%) and 15–17 (13.6%).
Māori and Pacific peoples record substantially higher daily vaping rates than European/Other and Asian populations.
Daily vaping prevalence is 21.1% among residents in the most socioeconomically deprived areas, compared with 7.2% in the most affluent communities, showing a clear concentration in disadvantaged areas.
As vaping uptake rises rapidly, the overall daily use of nicotine products in New Zealand increased from 14.7% in 2019/20 to 17.1% in 2024/25.
New regulations taking effect in June 2025—banning disposable vapes, restricting flavours and displays, and tightening enforcement on underage sales—are not yet reflected in this survey, with researchers calling for continued regulatory strengthening to balance harm reduction and prevention of new addiction.

2Firsts, December 5, 2025 — According to a report released by the Public Health Communication Centre Aotearoa (PHCC), based on the 2024–25 New Zealand Health Survey (NZHS) data titled “Vaping prevalence and trends: Findings from the 2024–25 NZ Health Survey”, daily vaping among New Zealand adults remains elevated, with significant disparities across youth, Indigenous and minority groups, and socioeconomically disadvantaged communities.

PHCC’s analysis of the 2024/25 NZHS shows that 11.7% of New Zealanders aged 15 and above vape daily, up slightly from 2023/24. By age group, daily use is highest among those aged 18–24 (23.0%), while 15–17-year-olds also record a notable rate of 13.6%. Individuals aged 25–34 have a daily prevalence of 20.5%.

By ethnicity, Māori and Pacific peoples show much higher daily vaping rates than European/Other and Asian populations, at 27.5% and 20.0% respectively.

Socioeconomic disparities are similarly pronounced. Daily vaping prevalence reaches 21.1% in the most deprived communities (deprivation quintile 5), compared with just 7.2% in the most affluent areas.

The report notes that although daily smoking rates have continued to fall in recent years, the rise in vaping has driven an increase in the overall proportion of people who use any nicotine product daily (either smoking or vaping), rising from 14.7% in 2019/20 to 17.1% in 2024/25.

The PHCC also highlights that forthcoming regulations—effective June 2025 and covering a ban on disposable vapes, restrictions on flavours and packaging/online displays, and stricter enforcement against sales to minors—are not reflected in this survey cycle.

While acknowledging that vaping may offer a lower-harm alternative for smokers, the report stresses public health concerns regarding uptake among people who have never smoked, particularly youth. Researchers call for further strengthening of regulatory measures to balance harm reduction with preventing new nicotine addiction.

Original report: Vaping prevalence and trends: Findings from the 2024-25 NZ Health Survey

Cover image: PHCC

References:

[1] Vaping prevalence and trends: Findings from the 2024-25 NZ Health Survey

Also Read:

[1] NZ Issues National High Alert on Etomidate-Laced Vapes After Hospitalisations

[2] PMI Compares Smoke-Free Policies in Three Countries: Japan and New Zealand Lead Tobacco Control, While Thailand’s Ban Stalls Harm Reduction

[3] New Zealand Health Ministry launches e-cigarette and nicotine pod procurement project for smoking cessation services

[4] NZ school principal says student vaping has eased markedly from the post-pandemic peak

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com